Coronavirus
Moderna Will Test a Booster Shot That Targets the South African COVID-19 Variant
The drugmaker Moderna is set to begin testing a new version of its Covid-19 vaccine that was specifically designed to target an emerging variant of the coronavirus that was first reported in South Africa.
The company announced Wednesday that it has shipped doses of its variant-specific booster shot to the National Institutes of Health for clinical trials. This development is part of Moderna’s efforts to counter strains of the coronavirus that are circulating and to get ahead of the constantly mutating virus.
“Moderna is committed to making as many updates to our vaccine as necessary until the pandemic is under control,” Moderna CEO Stéphane Bancel said in a statement.
